nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—forebrain—attention deficit hyperactivity disorder	0.0202	0.05	CbGeAlD
Acamprosate—GRIN2C—forebrain—attention deficit hyperactivity disorder	0.0154	0.0381	CbGeAlD
Acamprosate—GRIN2D—forebrain—attention deficit hyperactivity disorder	0.0143	0.0354	CbGeAlD
Acamprosate—GRIN3A—forebrain—attention deficit hyperactivity disorder	0.0134	0.0333	CbGeAlD
Acamprosate—GRM5—midbrain—attention deficit hyperactivity disorder	0.0133	0.033	CbGeAlD
Acamprosate—GRIN1—forebrain—attention deficit hyperactivity disorder	0.0127	0.0316	CbGeAlD
Acamprosate—GRIN2B—forebrain—attention deficit hyperactivity disorder	0.0122	0.0301	CbGeAlD
Acamprosate—GRM5—nervous system—attention deficit hyperactivity disorder	0.011	0.0272	CbGeAlD
Acamprosate—GRIN2A—forebrain—attention deficit hyperactivity disorder	0.0106	0.0263	CbGeAlD
Acamprosate—GRM5—central nervous system—attention deficit hyperactivity disorder	0.0105	0.0262	CbGeAlD
Acamprosate—GRM5—cerebellum—attention deficit hyperactivity disorder	0.0103	0.0256	CbGeAlD
Acamprosate—GRIN1—midbrain—attention deficit hyperactivity disorder	0.00841	0.0209	CbGeAlD
Acamprosate—GRM5—brain—attention deficit hyperactivity disorder	0.00838	0.0208	CbGeAlD
Acamprosate—GRIN2C—nervous system—attention deficit hyperactivity disorder	0.00835	0.0207	CbGeAlD
Acamprosate—GRIN2C—central nervous system—attention deficit hyperactivity disorder	0.00804	0.0199	CbGeAlD
Acamprosate—GRIN2C—cerebellum—attention deficit hyperactivity disorder	0.00786	0.0195	CbGeAlD
Acamprosate—GRIN2D—nervous system—attention deficit hyperactivity disorder	0.00776	0.0192	CbGeAlD
Acamprosate—GRIN2D—central nervous system—attention deficit hyperactivity disorder	0.00747	0.0185	CbGeAlD
Acamprosate—GRIN2D—cerebellum—attention deficit hyperactivity disorder	0.0073	0.0181	CbGeAlD
Acamprosate—GRIN3A—nervous system—attention deficit hyperactivity disorder	0.0073	0.0181	CbGeAlD
Acamprosate—GRIN3A—central nervous system—attention deficit hyperactivity disorder	0.00703	0.0174	CbGeAlD
Acamprosate—GRIN2A—midbrain—attention deficit hyperactivity disorder	0.00702	0.0174	CbGeAlD
Acamprosate—GRIN1—nervous system—attention deficit hyperactivity disorder	0.00692	0.0172	CbGeAlD
Acamprosate—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00669	0.0166	CbGeAlD
Acamprosate—GRIN1—central nervous system—attention deficit hyperactivity disorder	0.00666	0.0165	CbGeAlD
Acamprosate—GRIN2B—nervous system—attention deficit hyperactivity disorder	0.0066	0.0164	CbGeAlD
Acamprosate—GRIN1—cerebellum—attention deficit hyperactivity disorder	0.00651	0.0161	CbGeAlD
Acamprosate—GRIN2C—brain—attention deficit hyperactivity disorder	0.00638	0.0158	CbGeAlD
Acamprosate—GRIN2B—central nervous system—attention deficit hyperactivity disorder	0.00635	0.0158	CbGeAlD
Acamprosate—GRIN2B—cerebellum—attention deficit hyperactivity disorder	0.00621	0.0154	CbGeAlD
Acamprosate—GRIN2D—brain—attention deficit hyperactivity disorder	0.00593	0.0147	CbGeAlD
Acamprosate—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00591	0.0147	CbGeAlD
Acamprosate—GRIN2A—nervous system—attention deficit hyperactivity disorder	0.00577	0.0143	CbGeAlD
Acamprosate—SLC36A1—nervous system—attention deficit hyperactivity disorder	0.00573	0.0142	CbGeAlD
Acamprosate—GRIN3A—brain—attention deficit hyperactivity disorder	0.00558	0.0138	CbGeAlD
Acamprosate—GRIN2A—Hypothetical Network for Drug Addiction—DRD1—attention deficit hyperactivity disorder	0.00557	0.00933	CbGpPWpGaD
Acamprosate—GRIN2A—central nervous system—attention deficit hyperactivity disorder	0.00555	0.0138	CbGeAlD
Acamprosate—SLC36A1—central nervous system—attention deficit hyperactivity disorder	0.00552	0.0137	CbGeAlD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00547	0.00917	CbGpPWpGaD
Acamprosate—GRIN2A—cerebellum—attention deficit hyperactivity disorder	0.00543	0.0135	CbGeAlD
Acamprosate—SLC36A1—cerebellum—attention deficit hyperactivity disorder	0.00539	0.0134	CbGeAlD
Acamprosate—GRIN1—brain—attention deficit hyperactivity disorder	0.00529	0.0131	CbGeAlD
Acamprosate—GRIN2A—Hypothetical Network for Drug Addiction—DRD4—attention deficit hyperactivity disorder	0.00523	0.00877	CbGpPWpGaD
Acamprosate—GABRB3—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00523	0.00876	CbGpPWpGaD
Acamprosate—GABRB3—forebrain—attention deficit hyperactivity disorder	0.00514	0.0127	CbGeAlD
Acamprosate—GABRG2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00513	0.0086	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00509	0.00852	CbGpPWpGaD
Acamprosate—GRIN2B—brain—attention deficit hyperactivity disorder	0.00504	0.0125	CbGeAlD
Acamprosate—GRIN2A—Hypothetical Network for Drug Addiction—DRD2—attention deficit hyperactivity disorder	0.00488	0.00817	CbGpPWpGaD
Acamprosate—GRIN1—Hypothetical Network for Drug Addiction—DRD1—attention deficit hyperactivity disorder	0.00486	0.00814	CbGpPWpGaD
Acamprosate—GRIN2B—Hypothetical Network for Drug Addiction—DRD1—attention deficit hyperactivity disorder	0.00473	0.00793	CbGpPWpGaD
Acamprosate—GRIN1—Hypothetical Network for Drug Addiction—DRD4—attention deficit hyperactivity disorder	0.00457	0.00765	CbGpPWpGaD
Acamprosate—GABRA1—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00449	0.00752	CbGpPWpGaD
Acamprosate—GRIN2B—Hypothetical Network for Drug Addiction—DRD4—attention deficit hyperactivity disorder	0.00445	0.00746	CbGpPWpGaD
Acamprosate—GABRG2—midbrain—attention deficit hyperactivity disorder	0.00442	0.011	CbGeAlD
Acamprosate—GRIN2A—brain—attention deficit hyperactivity disorder	0.00441	0.0109	CbGeAlD
Acamprosate—SLC36A1—brain—attention deficit hyperactivity disorder	0.00438	0.0109	CbGeAlD
Acamprosate—GRIN1—Hypothetical Network for Drug Addiction—DRD2—attention deficit hyperactivity disorder	0.00425	0.00713	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00418	0.007	CbGpPWpGaD
Acamprosate—GRIN2B—Hypothetical Network for Drug Addiction—DRD2—attention deficit hyperactivity disorder	0.00415	0.00695	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00414	0.00694	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00411	0.00689	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—CACNA1C—attention deficit hyperactivity disorder	0.00405	0.00679	CbGpPWpGaD
Acamprosate—GABRA1—midbrain—attention deficit hyperactivity disorder	0.0039	0.00968	CbGeAlD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00382	0.00641	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00378	0.00634	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—CACNA1C—attention deficit hyperactivity disorder	0.00376	0.00631	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00364	0.00611	CbGpPWpGaD
Acamprosate—GABRG2—nervous system—attention deficit hyperactivity disorder	0.00363	0.00901	CbGeAlD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00355	0.00595	CbGpPWpGaD
Acamprosate—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.0035	0.00867	CbGeAlD
Acamprosate—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.00342	0.00848	CbGeAlD
Acamprosate—GABRB3—midbrain—attention deficit hyperactivity disorder	0.00339	0.00842	CbGeAlD
Acamprosate—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00321	0.00796	CbGeAlD
Acamprosate—GRIN2C—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00315	0.00528	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00314	0.00526	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—CACNA1C—attention deficit hyperactivity disorder	0.00309	0.00518	CbGpPWpGaD
Acamprosate—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00309	0.00766	CbGeAlD
Acamprosate—GABRB3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00305	0.00511	CbGpPWpGaD
Acamprosate—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00302	0.00749	CbGeAlD
Acamprosate—GABRG2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00299	0.00502	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—RTN4—attention deficit hyperactivity disorder	0.00298	0.00499	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00293	0.00491	CbGpPWpGaD
Acamprosate—GABRB3—nervous system—attention deficit hyperactivity disorder	0.00279	0.00692	CbGeAlD
Acamprosate—GABRG2—brain—attention deficit hyperactivity disorder	0.00278	0.00689	CbGeAlD
Acamprosate—GRIN1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00274	0.00459	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—CACNA1C—attention deficit hyperactivity disorder	0.0027	0.00452	CbGpPWpGaD
Acamprosate—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.00269	0.00666	CbGeAlD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00267	0.00447	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—CACNA1C—attention deficit hyperactivity disorder	0.00263	0.0044	CbGpPWpGaD
Acamprosate—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.00263	0.00651	CbGeAlD
Acamprosate—GABRA1—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00262	0.00439	CbGpPWpGaD
Acamprosate—GRIN1—Mecp2 and Associated Rett Syndrome—BDNF—attention deficit hyperactivity disorder	0.00255	0.00427	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00254	0.00425	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00249	0.00417	CbGpPWpGaD
Acamprosate—GABRA1—brain—attention deficit hyperactivity disorder	0.00245	0.00608	CbGeAlD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00241	0.00404	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00241	0.00403	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.0024	0.00403	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00236	0.00396	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00224	0.00375	CbGpPWpGaD
Acamprosate—GABRB3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00214	0.00358	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00214	0.00358	CbGpPWpGaD
Acamprosate—GABRB3—brain—attention deficit hyperactivity disorder	0.00213	0.00529	CbGeAlD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00211	0.00353	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0021	0.00353	CbGpPWpGaD
Acamprosate—GABRG2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0021	0.00352	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0021	0.00352	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00206	0.00346	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00205	0.00343	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00201	0.00336	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00196	0.00328	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00194	0.00325	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00184	0.00308	CbGpPWpGaD
Acamprosate—GABRA1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00184	0.00308	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00181	0.00303	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00181	0.00303	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00177	0.00297	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00172	0.00289	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00171	0.00287	CbGpPWpGaD
Acamprosate—GRM5—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.0017	0.00285	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00168	0.00282	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00168	0.00282	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00161	0.0027	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00161	0.00269	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.0016	0.00269	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00156	0.00262	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00156	0.00262	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00155	0.0026	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00152	0.00255	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00151	0.00252	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.0015	0.00251	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.0015	0.00251	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00147	0.00246	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00144	0.00241	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00143	0.0024	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00141	0.00235	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0014	0.00235	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0014	0.00235	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00139	0.00234	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00139	0.00232	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00138	0.00232	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00138	0.00232	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00137	0.00229	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00137	0.00229	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00137	0.00229	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00136	0.00228	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00136	0.00227	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00135	0.00227	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00133	0.00223	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00132	0.00221	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00132	0.00221	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0013	0.00218	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00129	0.00216	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00129	0.00216	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00129	0.00215	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00128	0.00214	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00128	0.00214	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00127	0.00212	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00124	0.00208	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00123	0.00206	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00123	0.00206	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00121	0.00202	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.0012	0.00201	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00119	0.00199	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00119	0.00199	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00118	0.00197	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00118	0.00197	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00115	0.00193	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00115	0.00192	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00115	0.00192	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00112	0.00188	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00109	0.00183	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00107	0.0018	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00107	0.00179	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00106	0.00177	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00106	0.00177	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00106	0.00177	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00105	0.00176	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00104	0.00174	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00103	0.00173	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00103	0.00172	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000999	0.00167	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000993	0.00166	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000985	0.00165	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000977	0.00164	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000974	0.00163	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000974	0.00163	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000974	0.00163	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000971	0.00163	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000968	0.00162	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000967	0.00162	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.000965	0.00162	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.000953	0.0016	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.000941	0.00158	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.000929	0.00156	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000925	0.00155	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000924	0.00155	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000909	0.00152	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000908	0.00152	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000908	0.00152	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000902	0.00151	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000901	0.00151	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000895	0.0015	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000884	0.00148	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000878	0.00147	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.000872	0.00146	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000859	0.00144	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000859	0.00144	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000851	0.00143	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00085	0.00142	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000849	0.00142	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000843	0.00141	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000839	0.00141	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000837	0.0014	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000833	0.0014	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000828	0.00139	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000822	0.00138	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000795	0.00133	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000794	0.00133	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000791	0.00133	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000781	0.00131	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00078	0.00131	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000774	0.0013	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000774	0.0013	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000773	0.0013	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000769	0.00129	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000766	0.00128	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000766	0.00128	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000765	0.00128	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000754	0.00126	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000753	0.00126	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000746	0.00125	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000746	0.00125	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000744	0.00125	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000744	0.00125	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000741	0.00124	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000739	0.00124	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000739	0.00124	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000732	0.00123	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000731	0.00122	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000726	0.00122	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000719	0.0012	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000709	0.00119	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000698	0.00117	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000696	0.00117	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000696	0.00117	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000693	0.00116	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000684	0.00115	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000683	0.00114	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00068	0.00114	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000676	0.00113	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00067	0.00112	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000663	0.00111	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000659	0.0011	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000651	0.00109	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000647	0.00108	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000646	0.00108	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000639	0.00107	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000635	0.00106	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000634	0.00106	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00063	0.00106	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000629	0.00105	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000622	0.00104	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000609	0.00102	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000608	0.00102	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000606	0.00102	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000598	0.001	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000583	0.000976	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000567	0.00095	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000566	0.000948	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000562	0.000942	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00056	0.000939	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000556	0.000933	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000556	0.000932	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00055	0.000922	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000546	0.000916	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000523	0.000877	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000522	0.000876	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000505	0.000846	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000496	0.000831	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000486	0.000815	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000485	0.000814	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000481	0.000806	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000478	0.0008	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000475	0.000796	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000457	0.000765	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000444	0.000745	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000441	0.000739	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000433	0.000726	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000429	0.00072	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000426	0.000715	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000425	0.000711	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000422	0.000707	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000419	0.000702	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000411	0.000689	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000404	0.000677	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000399	0.000669	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000372	0.000623	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000369	0.000618	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000366	0.000613	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000272	0.000455	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000267	0.000447	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00026	0.000436	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000252	0.000422	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000233	0.000391	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000177	0.000296	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000172	0.000289	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000138	0.000231	CbGpPWpGaD
